AI Article Synopsis
- Advances in Ewing's sarcoma treatment require focus on managing symptoms that affect daily life and quality of life for patients.
- A case study highlights a 25-year-old female nurse with pelvic Ewing's sarcoma who faced medication side effects and activity limitations due to chronic pain management.
- The use of dextrose prolotherapy relieved her pain, enabling her to stop taking pain medications and significantly enhance her quality of life, with improvements lasting three years post-treatment.
Article Abstract
Advances in the treatment and survival of Ewing's sarcoma patients create a need to treat underlying symptoms that limit activities of daily living and quality of life. This case describes the treatment of pain in a 25-year-old female pediatric nurse with Ewing's sarcoma of the pelvis that was in remission following radiation and chemotherapy. She reported medication side effects and limitations in her activities of daily living and quality of life with the chronic use of topical and oral pain medications. A dextrose prolotherapy approach was used to treat her pain, which allowed her to discontinue her pain medication regimen, resulting in an improvement in her activities of daily living and quality of life. The improvement was sustained at the three-year follow-up after the last procedure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000706 | PMC |
| http://dx.doi.org/10.7759/cureus.13549 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!